Quintiles and IMS Health have entered a global strategic alliance aimed at advancing the way biopharma companies generate real-world evidence (RWE) and apply critical insights to drive late-stage clinical research. The companies will leverage their real-world data management, operational delivery, advanced analytics, and scientific and therapeutic expertise in an effort to accelerate assessments of treatment and help improve patient outcomes.
 
The alliance offers IMS Health’s access to 500+ million anonymous patient records, as well as its scalable Evidence 360 RWE platform. Quintiles is providing experience in real-world and late-phase programs involving more than 74,000 sites and more than 650,000 enrolled patients in more than 100 countries, along with its Infosario platform. The companies anticipate that this combination will enable biopharma companies to optimize physician and patient recruitment, streamline data collection and study execution, as well as improve the quality and impact of real-world evidence worldwide.
 
“As demand increases for real-world evidence, biopharmaceutical companies need to integrate data from multiple sources to accelerate critical insights for stakeholders,” said Scott Evangelista, president, Integrated Healthcare Services at Quintiles. “This collaboration greatly enhances access to healthcare data from across the world – providing customers with the critical information and the related services needed to demonstrate the value of their medicines to physicians, payers and patients.”
 
“We are excited to offer an improved method for generating healthcare evidence that addresses a long-standing need for more robust information, greater insight on disease and treatment impact, and more cost-effective data collection,” said Jon Resnick, vice president and general manager, Real-World Evidence Solutions at IMS Health. “Through this collaboration, we will help improve the body of information healthcare stakeholders can access and use – informing better decisions that benefit patients and the entire health delivery system.”